{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:53Z","timestamp":1794047453278,"version":"4.8.0"},"reference-count":15,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"2","license":[{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2023.283200","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T16:06:57Z","timestamp":1692806817000},"page":"627-631","source":"Crossref","is-referenced-by-count":6,"title":["Identification of &lt;i&gt;PSMB4&lt;\/i&gt; and &lt;i&gt;PSMD4&lt;\/i&gt; as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma"],"prefix":"10.3324","volume":"109","author":[{"given":"Jessica Burroughs","family":"Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Storti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas Thomas","family":"Iannozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Marchica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Agnelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Toscani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Franceschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giannalisa","family":"Todaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Sammarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Notarfranchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Scita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta Dalla","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Raimondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oxana","family":"Lungu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Pruneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Donofrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Giuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"key":"57746","doi-asserted-by":"crossref","unstructured":"Pawlyn C, Morgan GJ. Evolutionary biology of high-risk multiple myeloma. Nat Rev Cancer. 2017; 17(9):543-556.","DOI":"10.1038\/nrc.2017.63"},{"key":"57747","doi-asserted-by":"crossref","unstructured":"Zhan F, Huang Y, Colla S. The molecular classification of multiple myeloma. Blood. 2006; 108(6):2020-2028.","DOI":"10.1182\/blood-2005-11-013458"},{"key":"57748","doi-asserted-by":"crossref","unstructured":"Perrot A, Lauwers-Cances V, Tournay E. Development and validation of a cytogenetic prognostic index predicting survival in multiple myeloma. J Clin Oncol. 2019; 37(19):1657-1665.","DOI":"10.1200\/JCO.18.00776"},{"key":"57749","doi-asserted-by":"crossref","unstructured":"Avet-Loiseau H, Attal M, Campion L. Long-term analysis of the IFM 99 trials for myeloma: cytogenetic abnormalities [t(4;14), del(17p), 1q gains] play a major role in defining longterm survival. J Clin Oncol. 2012; 30(16):1949-1952.","DOI":"10.1200\/JCO.2011.36.5726"},{"key":"57750","doi-asserted-by":"crossref","unstructured":"Hanamura I, Stewart JP, Huang Y. Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation. Blood. 2006; 108(5):1724-1732.","DOI":"10.1182\/blood-2006-03-009910"},{"key":"57751","doi-asserted-by":"crossref","unstructured":"An G, Li Z, Tai YT. The impact of clone size on the prognostic value of chromosome aberrations by fluorescence in situ hybridization in multiple myeloma. Clin Cancer Res. 2015; 21(9):2148-2156.","DOI":"10.1158\/1078-0432.CCR-14-2576"},{"key":"57752","doi-asserted-by":"crossref","unstructured":"Sawyer JR, Tian E, Heuck CJ. Evidence of an epigenetic origin for high-risk 1q21 copy number aberrations in multiple myeloma. Blood. 2015; 125(24):3756-3759.","DOI":"10.1182\/blood-2015-03-632075"},{"key":"57753","doi-asserted-by":"crossref","unstructured":"Neben K, Jauch A, Hielscher T. Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load. J Clin Oncol. 2013; 31(34):4325-4332.","DOI":"10.1200\/JCO.2012.48.4923"},{"key":"57754","doi-asserted-by":"crossref","unstructured":"Shaughnessy JD Jr, Qu P, Usmani S. Pharmacogenomics of bortezomib test-dosing identifies hyperexpression of proteasome genes, especially PSMD4, as novel high-risk feature in myeloma treated with Total Therapy 3. Blood. 2011; 118(13):3512-3524.","DOI":"10.1182\/blood-2010-12-328252"},{"key":"57755","doi-asserted-by":"crossref","unstructured":"D\u2019Agostino M, Ruggeri M, Aquino S. Impact of gain and amplification of 1q in newly diagnosed multiple myeloma patients receiving carfilzomib based treatment in the Forte trial. Blood. 2020; 136(Suppl 1):38-40.","DOI":"10.1182\/blood-2020-137060"},{"key":"57756","doi-asserted-by":"crossref","unstructured":"Schmidt TM, Barwick BG, Joseph N. Gain of chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone. Blood Cancer J. 2019; 9(12):94.","DOI":"10.1038\/s41408-019-0254-0"},{"key":"57757","doi-asserted-by":"crossref","unstructured":"Chiu M, Toscani D, Marchica V. Myeloma cells deplete bone marrow glutamine and inhibit osteoblast differentiation limiting asparagine availability. Cancers (Basel). 2020; 12(11):3267.","DOI":"10.3390\/cancers12113267"},{"key":"57758","doi-asserted-by":"crossref","unstructured":"Storti P, Agnelli L, Palma BD. The transcriptomic profile of CD138(+) cells from patients with early progression from smoldering to active multiple myeloma remains substantially unchanged. Haematologica. 2019; 104(10):e465-e469.","DOI":"10.3324\/haematol.2018.209999"},{"key":"57759","doi-asserted-by":"crossref","unstructured":"Hansen JD, Correa M, Nagy MA. Discovery of CRBN E3 ligase modulator CC-92480 for the treatment of relapsed and refractory multiple myeloma. J Med Chem. 2020; 63(13):6648-6676.","DOI":"10.1021\/acs.jmedchem.9b01928"},{"key":"57760","doi-asserted-by":"crossref","unstructured":"Richardson PG, Trudel S, Quach H. Mezigdomide (CC-92480), a potent, novel Cereblon E3 ligase modulator (CELMoD), combined with dexamethasone (DEX) in patients (pts) with relapsed\/refractory multiple myeloma (RRMM): preliminary results from the dose-expansion phase of the CC-92480-MM-001 Trial. Blood. 2022; 140(Suppl 1):1366-1368.","DOI":"10.1182\/blood-2022-157945"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.283200\/76011","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.283200\/76564","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11223\/76011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:04:42Z","timestamp":1794045882000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2023.283200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":15,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2023.283200","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,24]]}}}